Müjgan ARSLAN, Serdal GÜNGÖR, Betül KILIÇ, Kader Karlı OĞUZ

Neuromyelitis optica spectrum disorder: a pediatric case report

Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune demyelinating disorder of the central nervous system that predominantly affects the optic nerves and the spinal cord. Magnetic resonance imaging (MRI) has an increasingly important role in differentiating NMOSD from other inflammatory disorders of the central nervous system, particularly multiple sclerosis (MS). Specific antibodies against aquaporin-4 (AQP4) were identified and found to be directly responsible for the pathogenesis of the disease. We report on an AQP4 antibody-positive 12-year-old female with radiological findings in her brain MRI

PDF

___

1. Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carrol W, Chitnis T, de Seze J, Fujihara K, Greenberg B, Jacob A, Jarius S, Lana-Peixoto M, Levy M, Simon JH, Tenembaum S, Traboulsee AL, Waters P, Wellik KE, Weinshenker BG; International Panel for NMO Diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177-89.

2. Wingerchuk DM, Lennon VA, Lucchetti CF, Pittock SJ, Weinshenker BG. The spectrum of neuromyelitis optica. Lancet Neurol. 2007;6(9):805-15.

3. Melay MA, Wingerchuk DM, Greenberg BM, Levy M. Epidemiology of neuromyelitis optica in the United States:a multicenter analysis. Arch Neurol. 2012;69(9):1176-80.

4. Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG. A serum autoantibody marker of neuromyelitis optica: Distinction from multiple sclerosis. Lancet. 2004;364(9451):2106-12.

5. Papadopoulos MC, Verkman AS. Aquaporin-4 and neuromyelitis optica. Lancet Neurol 2012;11(6):535-44.

6. Wegner C. Recent insights into the pathology of multiple sclerosis and neuromyelitis optica. Clin Neurol Neurosurg. 2013;115(1):38- 41.

7. Huy SY, Min JH, Kim W, Kim BJ, Kim BJ, Lee KH. The usefulness of brain MRI at onset in the differentiation of multipe sclerosis and seropositive euromyelitis optica spectrum disorders. Mult Scler. 2014;20:695-704.

8. Ghezzi A, Bergamashi R, Martinelli V, Trojano M, Tola MR, Merelli E, Mancardi L, Gallo P, Filippi M, Zaffaroni M, Comi G; Italian Devic's Study Group (IDESG). Clinical characteristics, course and prognosis of relapsing Devic’s neuromyelitis optica. J Neurol. 2004;251(1):47-52.

9. Wingerchuk DM, Lennon VA, Pittock SJ, Luncchietti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66(10):1485-9.

10. Pittock SJ, Lennon VA, Krecke K, Wingerchuk DM, Luchinetti CF, Weinshenker BG. Brain abnormalities in neuromyelitis optica. Arch Neurol. 2006;63(3):390-6.

11. Ito S, Mori M, Makino T, Hayakawa S, Kuwabara S. Cloud-like enhancement’ is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Neurology. 2009;66(3):425-8

12. Kim SH, Kim W, Li XF, Jung IJ, Kim HJ. Clinical spectrum of CNS aquaporin-4 autoimmunity. Neurology. 2012;78(15):1179-85.

13. Cassinotto C, Deramod H, Olindo S, Aveillan M, Smadja D, Cabre P. MRI of the spinal cord in neuromyelitis optica and recurrent longitudinal extensive myelitis. J Neururad. 2009;36(4):199-205.

14. Nakamura M, Miyazawa I, Fujihara K, Nakashima I, Misu T, Watanabe S, Takahashi T, Itoyama Y. Preferential spinal cord grey matter involvement in neuromyelitis optica: an MRI study. J Neurol. 2008;255(2):163-70.

15. Lucchinetti CF, Guo Y, Popescu BF, Fujihara K, Itoyama Y, Misu T. The pathology of an autoimmune astrocythopathy: lessons learned from neuromyelitis optica. Brain Pathol. 2014;24(1):83-97.

16. Wang F, Liu Y, Duan Y, Li K. Brain MRI abnormalities in neuromyelitis optica. Eur J Radiol. 2011;80(2):445-9.

17. Pittock SJ, Wewinshenker BG, Lucchinetti CF, Wingechuk DM, Coroboy JR, Lennon VA. Neuromyelitis optica brain lesions localized at sites of high aquaporin-4 expression. Arch Neurol. 2006;63(7):964-8.

18. Kim W, Park MS, Lee SH, Jung IJ, Takahashi T, Misu T, Fujihara K, Kim HJ. Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity. Mult Scler. 2010;16(10):1229-36.

19. KimW, Kim SH, Huy SY, Kim HJ. Brain abnormalities in neuromyelitis optica spectrum disorder. Mult Scler Int. 2012;2012:735486.

20. Kitley JL, Leite MI, George JS, Palace JA. The differential diagnosis of longitudinally extensive transverse myelitis. Mult Scler. 2012;18(3):271-85.

21. Dale RC, Brilot F, Duffy LV, Twilt M, Waldman AT, Narula S, Muscal E, Deiva K, Andersen E, Eyre MR, Eleftheriou D, Brogan PA, Kneen R, Alper G, Anlar B, Wassmer E, Heineman K, Hemingway C, Riney CJ, Kornberg A, Tardieu M, Stocco A, Banwell B, Gorman MP, Benseler SM, Lim M. Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease. Neurology. 2014;83(2):142-50.

22. Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, Kleiter I, Kleinschnitz C, Berthele A, Brettschneider J, Hellwig K, Hemmer B, Linker RA, Lauda F, Mayer CA, Tumani H, Melms A, Trebst C, Stangel M, Marziniak M, Hoffmann F, Schippling S, Faiss JH, Neuhaus O, Ettrich B, Zentner C, Guthke K, Hofstadt-van Oy U, Reuss R, Pellkofer H, Ziemann U, Kern P, Wandinger KP, Bergh FT, Boettcher T, Langel S, Liebetrau M, Rommer PS, Niehaus S, Münch C, Winkelmann A, Zettl U UK, Metz I, Veauthier C, Sieb JP, Wilke C, Hartung HP, Aktas O, Paul F. Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation. 2012;9:14.

23. Kitley J, Woodhall M, Waters P, Leite MI, Devenney E, Craig J, Palace J, Vincent A. Myelin-oligodendocyte glycoprotein antibodies in adults with neuromyelitis optica phenotype. Neurology. 2012;79(12):1273-7.